| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |